US4139633A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical preparations for the treatment of hypertonia
Assignee: Novartis Corp
•
Filing: 1976-02-27
•
Granted: 1979-02-13
•
Expires: 1996-02-27
Abstract
Abstract The present invention relates to new pharmaceutical preparations comprising a β-receptor blocking agent and a diuretic, processes for their preparation and the use of said preparations for the treatment of hypertonia.
Inventors
- 👤 Hellmut Brunner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 04:46
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/40
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
51 words
A pharmaceutical preparation with anti-hypertensive properties comprising an amount of 20 mg to 160 mg of a beta-blocking agent selected from the group consisting of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane or 1-[4-(2-methoxyethyl)-phenoxy]-2-hydroxy-3-isopropylaminopropane in the free form or in the form of its non-toxic salts and an amount of 10 mg to 25 mg of 2-chloro-5-(1-hydroxy-3-oxo-1-ioindolinyl)-benzene-sulphonamide.
Claim 2
Dependent Claim
51 words
A pharmaceutical preparation with anti-hypertensive properties comprising an amount of 20 mg to 160 mg of a beta-blocking agent selected from the group consisting of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane or 1-[4-(2-methoxyethyl)-phenoxy]-2-hydroxy-3-isopropylaminopropane in the free form or in the form of its non-toxic salts and an amount of 10 mg to 25 mg of 2-chloro-5-(1-hydroxy-3-oxo-1-ioindolinyl)-benzene-sulphonamide.
Claim 3
Dependent Claim
17 words
Pharmaceutical preparation according to claim 1, containing 80 mg of 1-(2-allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride and 10 mg of 2-chloro-5-[1-hydroxy-3-oxo-1-isoindolinyl]-benzenesulphonamide.
Claim 4
Dependent Claim
17 words
Pharmaceutical preparation according to claim 1, containing 100 mg of 1-[4-(2-methoxyethyl)-phenoxy]-2-hydroxy-3-isopropylaminopropane-(2:1) tartrate and 25 mg of 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)-benzenesulphonamide.
Claim 5
Dependent Claim
17 words
Pharmaceutical preparation according to claim 1, containing 100 mg of 1-[4-(2-methoxyethyl)-phenoxy]-2-hydroxy-3-isopropylaminopropane-(2:1) tartrate and 12,5 mg of 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)-benzenesulphonamide.
Claim 6
Dependent Claim
9 words
Pharmaceutical preparation according to claim 1, containing potassium chloride.
Claim 7
Dependent Claim
14 words
Pharmaceutical preparation according to claim 1, containing 200 to 800 mg of potassium chloride.
Claim 8
Dependent Claim
26 words
Method for the treatment of hypertonia, characterised in that a pharmaceutical preparation according to claim 1 is administered to a warm-blooded organism in need of treatment.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-02-12 | 1982-08-14 | 1983-02-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-02-12 | 1986-08-14 | 1987-02-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-02-12 | 1990-08-14 | 1991-02-13 | $7700.00 | Window Closed / Lapsed |